Paxillin suppresses the proliferation of HPS rat serum treat…

Emerging


8
Citations
30
Refs
2013
Year
Search Works
Work Details
  • DOI 10.1039/c3mb70391f
  • PMID https://pubmed.ncbi.nlm.nih.gov/24457422
  • OpenAlex ID W2172287224
  • Type Article
  • Language EN
  • Published 29 Nov 2013
  • Volume 10 (4)
  • Pages 759–766
  • Source Molecular BioSystems
  • Publisher Royal Society of Chemistry
  • FWCI 1.35
  • Countries 1
  • Institutions 2
  • Added 24 Jun 2016
  • Updated 31 Oct 2026
MENU
0

Paxillin suppresses the proliferation of HPS rat serum treated PASMCs by up-regulating the expression of cytoskeletal proteins

Article 2013 EN

Hepatopulmonary syndrome (HPS) is a triad of advanced liver disease, intrapulmonary vasodilatation (IPVD), and arterial hypoxemia. The arterial hypoxemia induces pulmonary vascular remodelling (PVR). In recent studies, the role of the proliferation of pulmonary artery smooth muscle cells (PASMCs) in PVR associated with HPS has been established; the changes in cytoskeletal proteins play an essentia…

8

Citations

30

References

7

Authors

1.35

FWCI

Citations by Year
Last 6 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
7 authors
#AuthorInstitutionsORCID
1 Yang Chen Army Medical University (CN) Southwest Hospital (CN)
2 Bin Yi Army Medical University (CN) Southwest Hospital (CN)
3 Zhi Wang Army Medical University (CN) Southwest Hospital (CN)
4 Jianteng Gu Army Medical University (CN) Southwest Hospital (CN)
5 Yongshuai Li Army Medical University (CN) Southwest Hospital (CN) —
6 Jian Guo Cui Army Medical University (CN) Southwest Hospital (CN)
7 Kaizhi Lu Corresponding Army Medical University (CN) Southwest Hospital (CN)

Data: OpenAlex